Skip to main content
Barnes-Jewish Medical Professional Education Center
  • Specialties
    • Heart & Vascular

    • Neurology & Neurosurgery

    • Oncology

    • Orthopedics

    • Trauma

    • Women & Infants

  • Pediatrics
  • Refer a Patient
  • Operations and Safety
close

Paul Eisenberg, MD

Senior Vice President, Global Medical and Chief Medical Officer Amgen

Paul Eisenberg, MD


Related Videos

Challenges in the Development of Novel Cardiovascular Therapies: New Target for Lowering LDL: PCSK-9 - Cardiology Grand Rounds

Challenges in the Development of Novel Cardiovascular Therapies: New Target for Lowering LDL: PCSK-9 - Cardiology Grand Rounds

Chief Medical Officer of Amgen, Paul Eisenberg, MD, discusses the insights he has learned working on drug development, specifically the cardiovacscular drug that lowers LDL, PCSK-9.

One Barnes-Jewish Hospital Plaza
St. Louis, MO 63110
© Copyright 1997-2025, Barnes-Jewish Hospital. All Rights Reserved.